Spironolactone Versus Bicalutamide in Female Pattern Hair Loss: A Randomized Clinical Trial
February 2026
in “
Clinical and Experimental Dermatology
”
Studysummary In this randomized trial, bicalutamide was found to improve hair count and shaft diameter more than spironolactone in women with Female Pattern Hair Loss over 24 weeks, although no significant differences were observed in clinical endpoints between the two treatments.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer